Atezolizumab vs Sorafenib Tosylate

## Atezolizumab vs Sorafenib Tosylate: Overview

This comparison examines the pharmacological differences between **Atezolizumab** and **Sorafenib Tosylate**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

## Pharmacokinetics

**Half-life**: Atezolizumab — 27 days; Sorafenib Tosylate — N/A.

## Chemical Properties

**Type**: Atezolizumab — Antibody; Sorafenib Tosylate — Small molecule.